LJAC
GBT

L.J. Altfest & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

L.J. Altfest & Co’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,663
Closed -$353K – 304
2021
Q1 		$353K Buy
8,663
+137
+2% +$6.3K 0.08% 185
2020
Q4 		$369K Buy
8,526
+4,387
+106% +$216K 0.09% 165
2020
Q3 		$228K Buy
4,139
+818
+25% +$52K 0.06% 201
2020
Q2 		$210K Buy
+3,321
New +$228K 0.06% 201

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

L.J. Altfest & Co's GBT Position: Q2 2021 in Review

L.J. Altfest & Co sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 8,663 shares — an estimated $353K sold.

L.J. Altfest & Co first reported a position in GBT in Q2 2020 and held it in 4 quarters. The position peaked at $369K in Q4 2020. 191 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

  • L.J. Altfest & Co reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • L.J. Altfest & Co sold 8,663 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $353K.
  • L.J. Altfest & Co first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 4 quarters.
  • L.J. Altfest & Co's Global Blood Therapeutics, Inc. position peaked at $369K in Q4 2020.
  • 191 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on L.J. Altfest & Co's 13F filing for Q2 2021, filed 28 Jul 2021.